DIF-1 inhibits the Wnt/β-catenin signaling pathway by inhibiting TCF7L2 expression in colon cancer cell lines.

We previously reported that differentiation-inducing factor-1 (DIF-1), a morphogen in Dictyostelium discoideum, inhibits the proliferation of human cancer cell lines by inducing β-catenin degradation and suppressing the Wnt/β-catenin signaling pathway. To determine whether β-catenin degradation is essential for the effect of DIF-1, we examined the effect of DIF-1 on human colon cancer cell lines (HCT-116, SW-620 and DLD-1), in which the Wnt/β-catenin signaling pathway is constitutively active. DIF-1 strongly inhibited cell proliferation and arrested the cell cycle in the G(0)/G(1) phase via the suppression of cyclin D1 expression at mRNA and protein levels without reducing β-catenin protein. TCF-dependent transcriptional activity and cyclin D1 promoter activity were revealed to be inhibited via suppression of transcription factor 7-like 2 (TCF7L2) expression. Luciferase reporter assays and EMSAs using the TCF7L2 promoter fragments indicated that the binding site for the transcription factor early growth response-1 (Egr-1), which is located in the -609 to -601 bp region relative to the start codon in the TCF7L2 promoter, was involved in DIF-1 activity. Moreover, RNAi-mediated depletion of endogenous TCF7L2 resulted in reduced cyclin D1 promoter activity and protein expression, and the overexpression of TCF7L2 overrode the inhibition of the TCF-dependent transcriptional activity and cyclin D1 promoter activity induced by DIF-1. Therefore, DIF-1 seemed to inhibit the Wnt/β-catenin signaling pathway by suppressing TCF7L2 expression via reduced Egr-1-dependent transcriptional activity in these colon cancer cell lines. Our results provide a novel insight into the mechanisms by which DIF-1 inhibits the Wnt/β-catenin signaling pathway.

[1]  M. Hirata,et al.  Differentiation-inducing factor-1 induces cyclin D1 degradation through the phosphorylation of Thr286 in squamous cell carcinoma. , 2005, Experimental cell research.

[2]  D. Mercola,et al.  Decreased Egr‐1 expression in human, mouse and rat mammary cells and tissues correlates with tumor formation , 1997, International journal of cancer.

[3]  Hans Clevers,et al.  Activation of β-Catenin-Tcf Signaling in Colon Cancer by Mutations in β-Catenin or APC , 1997, Science.

[4]  M. Saegusa,et al.  Transcription factor Egr1 acts as an upstream regulator of β‐catenin signalling through up‐regulation of TCF4 and p300 expression during trans‐differentiation of endometrial carcinoma cells , 2008, The Journal of pathology.

[5]  D. Mercola,et al.  The transcription factor Egr1 is a direct regulator of multiple tumor suppressors including TGFβ1, PTEN, p53, and fibronectin , 2006, Cancer Gene Therapy.

[6]  R. Kay,et al.  Chemical structure of the morphogen differentiation inducing factor from Dictyostelium discoideum , 1987, Nature.

[7]  Michael Kahn,et al.  Targeting Wnt Signaling: Can We Safely Eradicate Cancer Stem Cells? , 2010, Clinical Cancer Research.

[8]  M. Waterman,et al.  Lymphoid enhancer factor/T cell factor expression in colorectal cancer , 2004, Cancer and Metastasis Reviews.

[9]  G. Zaman,et al.  New avenues to target Wnt/β-catenin signaling. , 2011, Drug discovery today.

[10]  J. Xu,et al.  Curcumin inhibits human colon cancer cell growth by suppressing gene expression of epidermal growth factor receptor through reducing the activity of the transcription factor Egr-1 , 2006, Oncogene.

[11]  D. Mercola,et al.  Egr1 Promotes Growth and Survival of Prostate Cancer Cells , 2003, The Journal of Biological Chemistry.

[12]  M. Hirata,et al.  Differentiation-inducing factor-1 suppresses gene expression of cyclin D1 in tumor cells. , 2005, Biochemical and biophysical research communications.

[13]  Levon M Khachigian,et al.  Transcription factor Egr-1 supports FGF-dependent angiogenesis during neovascularization and tumor growth , 2003, Nature Medicine.

[14]  Hetian Wang,et al.  E2F1 Induces tumor cell survival via nuclear factor-kappaB-dependent induction of EGR1 transcription in prostate cancer cells. , 2009, Cancer research.

[15]  Y. Kubohara.  DIF-1, putative morphogen of D. discoideum, suppresses cell growth and promotes retinoic acid-induced cell differentiation in HL-60. , 1997, Biochemical and biophysical research communications.

[16]  M. Roussel,et al.  Glycogen synthase kinase-3beta regulates cyclin D1 proteolysis and subcellular localization. , 1998, Genes & development.

[17]  W. Birchmeier,et al.  Wnt signalling and its impact on development and cancer , 2008, Nature Reviews Cancer.

[18]  T. Sasaguri,et al.  Differentiation-inducing factor-1, a morphogen of dictyostelium, induces G(1) arrest and differentiation of vascular smooth muscle cells. , 2000, Circulation research.

[19]  Setsuo Hirohashi,et al.  Wnt signaling inside the nucleus , 2008, Cancer science.

[20]  F. Zindy,et al.  Inhibition of cyclin D1 phosphorylation on threonine-286 prevents its rapid degradation via the ubiquitin-proteasome pathway. , 1997, Genes & development.

[21]  M. von Knebel Doeberitz,et al.  Wnt/β‐catenin‐pathway as a molecular target for future anti‐cancer therapeutics , 2005 .

[22]  Giuseppe Cibelli,et al.  Regulation of life and death by the zinc finger transcription factor Egr‐1 , 2002, Journal of cellular physiology.

[23]  P. Humphrey,et al.  Impaired prostate tumorigenesis in Egr1-deficient mice , 2001, Nature Medicine.

[24]  M. Hirata,et al.  Differentiation‐Inducing Factor‐1 Alters Canonical Wnt Signaling and Suppresses Alkaline Phosphatase Expression in Osteoblast‐Like Cell Lines , 2006, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[25]  N. Wright,et al.  Mechanisms of Disease: from stem cells to colorectal cancer , 2006, Nature Clinical Practice Gastroenterology &Hepatology.

[26]  Frank McCormick,et al.  β-Catenin regulates expression of cyclin D1 in colon carcinoma cells , 1999, Nature.

[27]  M. Hirata,et al.  Involvement of GSK-3β and DYRK1B in Differentiation-inducing Factor-3-induced Phosphorylation of Cyclin D1 in HeLa Cells* , 2006, Journal of Biological Chemistry.

[28]  T. Mustelin,et al.  A network of p73, p53 and Egr1 is required for efficient apoptosis in tumor cells , 2007, Cell Death and Differentiation.

[29]  R. Nusse,et al.  Convergence of Wnt, ß-Catenin, and Cadherin Pathways , 2004, Science.

[30]  Yusuke Nakamura,et al.  AXIN1 mutations in hepatocellular carcinomas, and growth suppression in cancer cells by virus-mediated transfer of AXIN1 , 2000, Nature Genetics.

[31]  M. Hirata,et al.  Dictyostelium Differentiation-inducing Factor-3 Activates Glycogen Synthase Kinase-3β and Degrades Cyclin D1 in Mammalian Cells* , 2003, The Journal of Biological Chemistry.

[32]  N. Perrimon,et al.  The Promise and Perils of Wnt Signaling Through β-Catenin , 2002, Science.

[33]  K. Garber.  Drugging the Wnt pathway: problems and progress. , 2009, Journal of the National Cancer Institute.

[34]  S. Abdulkadir,et al.  Early Growth Response Gene 1 Modulates Androgen Receptor Signaling in Prostate Carcinoma Cells* , 2003, Journal of Biological Chemistry.

[35]  M. Hirata,et al.  Dictyostelium differentiation-inducing factor-1 binds to mitochondrial malate dehydrogenase and inhibits its activity. , 2010, Journal of pharmacological sciences.

[36]  Harold E. Varmus,et al.  Many tumors induced by the mouse mammary tumor virus contain a provirus integrated in the same region of the host genome , 1982, Cell.

[37]  H. Clevers,et al.  Wnt signalling in stem cells and cancer , 2005, Nature.

[38]  R. Kay,et al.  Structure elucidation of two differentiation inducing factors (DIF-2 and DIF-3) from the cellular slime mould Dictyostelium discoideum. , 1988, The Biochemical journal.

[39]  T. Akiyama.  Wnt/beta-catenin signaling. , 2000, Cytokine & growth factor reviews.

[40]  I. Tomlinson,et al.  Colorectal cancer and genetic alterations in the Wnt pathway , 2006, Oncogene.

[41]  J. Behrens,et al.  The canonical Wnt signalling pathway and its APC partner in colon cancer development , 2006, Gut.

[42]  Hans Clevers,et al.  Wnt/β-Catenin Signaling in Development and Disease , 2006, Cell.

[43]  Y. Kubohara.  Effects of differentiation-inducing factors of Dictyostelium discoideum on human leukemia K562 cells: DIF-3 is the most potent anti-leukemic agent. , 1999, European journal of pharmacology.

[44]  Y. Kubohara,et al.  Differentiation‐inducing factor of D. discoideum raises intracellular calcium concentration and suppresses cell growth in rat pancreatic AR42J cells , 1995, FEBS letters.

[45]  M. Hirata,et al.  Anti-angiogenic effects of differentiation-inducing factor-1 involving VEGFR-2 expression inhibition independent of the Wnt/β-catenin signaling pathway , 2010, Molecular Cancer.

[46]  Joseph M. Wallace,et al.  Wnt / β-catenin signaling , 2008 .

[47]  Xi He,et al.  Destruction of a destructor: a new avenue for cancer therapeutics targeting the Wnt pathway. , 2010, Journal of molecular cell biology.